Rafferty Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-220,661
| Closed | -$2.17M | – | 1115 |
|
|
2023
Q1 | $2.17M | Sell |
220,661
-26,265
| -11% | -$258K | 0.01% | 593 |
|
|
2022
Q4 | $4.62M | Buy |
246,926
+49,994
| +25% | +$936K | 0.04% | 384 |
|
|
2022
Q3 | $4.08M | Buy |
196,932
+24,282
| +14% | +$503K | 0.04% | 369 |
|
|
2022
Q2 | $3.58M | Buy |
172,650
+7,665
| +5% | +$159K | 0.03% | 352 |
|
|
2022
Q1 | $7.11M | Buy |
164,985
+62,312
| +61% | +$2.68M | 0.04% | 266 |
|
|
2021
Q4 | $6.15M | Buy |
102,673
+40,285
| +65% | +$2.41M | 0.03% | 291 |
|
|
2021
Q3 | $5.36M | Buy |
62,388
+7,059
| +13% | +$606K | 0.04% | 295 |
|
|
2021
Q2 | $6.16M | Sell |
55,329
-2,278
| -4% | -$253K | 0.04% | 270 |
|
|
2021
Q1 | $6.42M | Buy |
57,607
+46,084
| +400% | +$5.13M | 0.04% | 239 |
|
|
2020
Q4 | $1.22M | Sell |
11,523
-4,881
| -30% | -$518K | 0.01% | 466 |
|
|
2020
Q3 | $2.28M | Buy |
16,404
+10,292
| +168% | +$1.43M | 0.03% | 374 |
|
|
2020
Q2 | $1.98M | Buy |
+6,112
| New | +$1.98M | 0.03% | 356 |
|
|
2019
Q2 | – | Sell |
-15,713
| Closed | -$703K | – | 829 |
|
|
2019
Q1 | $703K | Buy |
+15,713
| New | +$703K | 0.01% | 608 |
|